chr19-1206334-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_000455.5(STK11):c.-580G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000677 in 228,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00094 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00017 ( 0 hom. )
Consequence
STK11
NM_000455.5 5_prime_UTR
NM_000455.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.170
Genes affected
STK11 (HGNC:11389): (serine/threonine kinase 11) The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 19-1206334-G-A is Benign according to our data. Variant chr19-1206334-G-A is described in ClinVar as [Benign]. Clinvar id is 888659.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000939 (142/151302) while in subpopulation AFR AF= 0.00331 (137/41364). AF 95% confidence interval is 0.00286. There are 0 homozygotes in gnomad4. There are 79 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 142 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.-580G>A | 5_prime_UTR_variant | 1/10 | ENST00000326873.12 | ||
STK11 | NM_001407255.1 | c.-580G>A | 5_prime_UTR_variant | 1/9 | |||
STK11 | NR_176325.1 | n.557G>A | non_coding_transcript_exon_variant | 1/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.-580G>A | 5_prime_UTR_variant | 1/10 | 1 | NM_000455.5 | P1 | ||
STK11 | ENST00000585465.3 | c.-580G>A | 5_prime_UTR_variant | 1/10 | 5 | ||||
STK11 | ENST00000652231.1 | c.-580G>A | 5_prime_UTR_variant | 1/9 | |||||
STK11 | ENST00000585748.3 | c.-82-12083G>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000926 AC: 140AN: 151194Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
140
AN:
151194
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000167 AC: 13AN: 77622Hom.: 0 Cov.: 0 AF XY: 0.000167 AC XY: 6AN XY: 35868
GnomAD4 exome
AF:
AC:
13
AN:
77622
Hom.:
Cov.:
0
AF XY:
AC XY:
6
AN XY:
35868
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000939 AC: 142AN: 151302Hom.: 0 Cov.: 31 AF XY: 0.00107 AC XY: 79AN XY: 73920
GnomAD4 genome
AF:
AC:
142
AN:
151302
Hom.:
Cov.:
31
AF XY:
AC XY:
79
AN XY:
73920
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Peutz-Jeghers syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 16, 2018 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at